Calithera Biosciences Inc (CALA) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Calithera Biosciences Inc   (NASDAQ: CALA)


Calithera Biosciences Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Calithera Biosciences Inc's ROI in the fourth quarter of 2022?
Calithera Biosciences Inc recorded a cumulative net loss of $-21 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -68.31%.

Within the Healthcare sector 817 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 5039.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM -59.71 % -57.87 % -51.43 % -47.73 % -40.27 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 21 28 37 39 51
Return On Investment (TTM) -68.31 % -220.41 % -170.28 % -172.66 % -148.77 %
CALA's Overall Ranking # 5039 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -19.12 % -23.97 % -19.38 % -18.75 % -15.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -21 -85 -86 -109 -115

CALA Company Profile >> Back to CALA Roi Comparisons >> See Annual CALA Return On Investment



Return On Investment CALA's Ranking
Within: No.
Industry # 370
Sector # 818
Overall # 5039

Return On Investment Statistics
High Average Low
-16.1 %
-75.51 %
-220.41 %
(Dec 31 2017)   (Sep 30 2022)







Financial Statements
Calithera Biosciences Inc's IV. Quarter Investments $ 21 Millions CALA's Balance sheet
Calithera Biosciences Inc's IV. Quarter Income $ -6 Millions Quarterly CALA's Income Statement
CALA's Income by Division See CALA's Income by Division


CALA Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 21 51 107 149 128
Y / Y Investment Growth -58.06 % -52.65 % -28.13 % 16.66 % -16.67 %
Net Income in Millions -21 -115 -90 -90 -55
Y / Y Net Income Growth - - - - -
Annual Return On Investment -100.02 % -226.77 % -84.09 % -60.25 % -42.73 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CALA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CALA's Competitors
Subscribers only: Roi for Calithera Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CALA's Customers

Other Ratios
CALA's Roa CALA's Inventory Turnover Ratio CALA's Growth Rates CALA's Dividend Statistics
CALA's Profitability Ratios CALA's Asset Turnover Ratio CALA's Dividend Growth
CALA's Roe CALA's Valuation Ratios CALA's Financial Strength Ratios CALA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.